Thus, blocking CD47 could enhance anti-tumor innate immunity mediated by macrophages and anti-tumor adaptive immunity indirectly via suppressing immunosuppressive signals in antigen presenting cells [65, 66] and directly via activating T cell cytotoxicity. This evidence concerns the gene CD47 and neoplasm.